Association of hepatitis C virus infection status and genotype with kidney disease risk: A population-based cross-sectional study

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 藥學系(所) > 期刊論文 > Item 310902800/34688

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34688

標題:	Association of hepatitis C virus infection status and genotype with kidney disease risk: A population-based cross-sectional study
作者:	Chen, Yi-Chia Wang, Hung-Wei Huang, Yun-Ting Jiang, Ming-Yan
貢獻者:	Chi Mei Hospital Chi Mei Hospital Department of Pharmacy, Chia Nan University of Pharmacy & Science
關鍵字:	viral load progression increases
日期:	2022
上傳時間:	2023-12-11 14:05:14 (UTC+8)
出版者:	PUBLIC LIBRARY SCIENCE
摘要:	Background Whether there is difference in kidney disease risk between chronic hepatitis C virus (HCV) infection and resolved HCV infection remains inconclusive. Additionally, the impact of different HCV genotypes on kidney disease risk is relatively unknown. Accordingly, we conducted a population-based cross-sectional study to investigate the association of HCV infection status and genotype on kidney disease risk. Methods The study population were adult participants of 1999-2018 National Health and Nutrition Examination Survey in the United States. Chronic and resolved infection were defined as HCV seropositivity with and without detectable HCV RNA, respectively. HCV genotypes were classified into genotype 1, genotype 2, and other genotypes. Prevalent estimated glomerular filtration rate < 60 ml/min/1.73 m(2) or urinary albumin creatinine ratio. 30 mg/g was defined as kidney disease. Results The average age of study population (n = 44,998) was 46.7 +/- 17.0 years with 49.8% being males. Compared with individuals without HCV infection (n = 44,157), those with resolved (n = 255) or chronic HCV infection (n = 586) had higher prevalence of kidney disease: 14.8%, 23.5%, and 20.1%, respectively (p< 0.001). After adjusting for potential confounders, we found that both resolved (adjusted OR: 1.40, 95% CI: 1.02-1.93) and chronic HCV infection (adjusted OR: 1.26, 95% CI: 1.01-1.57) correlated to increased kidney disease risk compared with no HCV infection. Additionally, individuals with HCV genotype 1 (adjusted OR: 1.41, 95% CI: 1.09-1.82) but not genotype 2 or other genotypes had greater kidney disease risk compared with no HCV infection. Furthermore, we observed that genotype 1 had 2-fold higher kidney disease risk (adjusted OR: 2.20, 95% CI: 1.07-4.53) compared with nongenotype 1 HCV infection. Conclusion Both resolved and chronic HCV infection, particularly genotype 1, were associated with higher kidney disease risk.
關聯:	PLOS ONE, v.17, n.7, e0271197.
显示于类别:	[藥學系(所)] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	197	检视/开启
journal.pone.0271197.pdf		956Kb	Adobe PDF	148	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....